Core Laboratories Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | $22.7M | $19.2M | $15.1M | $15.4M | $17.7M |
| Accounts Receivable | $113.5M | $111.8M | $109.4M | $106.9M | — |
| Inventory | $54.5M | $59.4M | $71.7M | $60.4M | — |
| Total Current Assets | $214.7M | $221.3M | $223.1M | $211.7M | — |
| Property, Plant & Equipment | $99.4M | $97.1M | $99.6M | $105.0M | $111.0M |
| Goodwill | $105.8M | $99.4M | $99.4M | $99.4M | — |
| Intangible Assets (Excl. Goodwill) | $7.1M | $6.4M | $6.9M | $7.5M | — |
| Total Assets | $584.0M | $585.1M | $586.4M | $578.4M | $580.9M |
| Liabilities | |||||
| Accounts Payable | $37.3M | $34.5M | $33.5M | $45.8M | — |
| Total Current Liabilities | $106.0M | $102.4M | $88.1M | $103.1M | — |
| Long-Term Debt | $110.3M | $126.1M | $163.1M | $172.4M | — |
| Total Liabilities | $318.0M | $338.6M | $361.6M | $394.1M | $419.9M |
| Stockholders' Equity | |||||
| Retained Earnings | $172.7M | $144.9M | $120.8M | $85.9M | — |
| Total Stockholders' Equity | $266.0M | $246.6M | $224.8M | $184.3M | $161.0M |